載入...
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Immune-checkpoint blocking antibodies have demonstrated objective antitumor responses in multiple tumor types including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC). In melanoma, an increase in overall survival has been demonstrated with anti-CTLA-4 and PD-1 inhibition....
Na minha lista:
| 發表在: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4986340/ https://ncbi.nlm.nih.gov/pubmed/27532025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0152-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|